Please wait
Abbott Laboratories (ABT) is listed on the Nigerian Exchange in the Healthcare sector, with exposure to Medical Devices. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
Healthcare
₦246T
2.7%
26.36
Current price
₦141,180.00
Updated Updated 1 min ago
Conviction
80/100
Confidence
Low
Market tone
neutral · 80/100
Entry
Medium · 80/100
ABT has a strong upside over 30 days and strong upside over one year.
7-day forecast is free
You can use the full 7-day forecast on the free plan. Upgrade to Pro to unlock the 30-day and 1-year views.
Expected move
+3.51%
Expected price
₦146,130.00
Lower path
₦139,860.00
Upper path
₦152,400.00
Confidence
Director dealings
0
Reported buys, sells, and mixed dealings.
Corporate actions
0
Dividend and company notices.
Market events
0
Insider, filing, dividend, and price events.
Source records
3
Captured updates we can trace.
Whisone is bullish because fundamentals are solid at 80/100 while there is no strong bear warning from the current data. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
ROE
12.3%
Return on equity
ROA
5.6%
Return on assets
Debt / equity
0.65
Lower is usually safer.
P/B ratio
29.89
Useful for book value support.
Dividend yield
2.7%
Current income signal.
99/100
Direction
Positive bias
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Valuation still leaves room versus fair value and analyst anchors.
Recent price behavior and momentum still support follow-through.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
₦555,915.00
Analyst view
Buy
Analyst target
₦174,810.00
Forecast refresh
Updated 1h ago
Quality score
79
Growth score
63.67
These are the external analyst numbers and business outlook figures already synced into the company record.
Low target
₦71,700,000,000,000.00
High target
₦75,900,000,000,000.00
Revenue this year
₦75.4T
Revenue next year
₦82.2T
EPS this year
₦8,220.00
EPS next year
₦9,090.00
Dividend / share
₦2,730.00
Forward P/E
30.05
US stock catalog seed
Updated 2d ago
Seeded from the built-in US stock catalog for database discovery and later background refresh.
Price points saved
50
Latest market date
2026-06-26
Dividend yield
2.7%
Ex-dividend date
Jul 15, 2026
ABT
Abbott Laboratories
Price: ₦141,180.00
P/E: 26.36
Yield: 2.7%
ABBV
AbbVie Inc.
Price: ₦380,025.00
P/E: 124.8
Yield: 2.7%
AMGN
Amgen Inc.
Price: ₦537,495.00
P/E: 24.94
Yield: 2.8%
BMY
Bristol-Myers Squibb Company
Price: ₦86,280.00
P/E: N/A
Yield: N/A
Industry
Medical Devices
Founded
1888
Employees
115,000
Exchange
NYSE
Ticker
ABT
